TRAD CHI MED (00570) Sets 20 March 2026 Board Meeting to Approve FY 2025 Results and Evaluate Final Dividend

Bulletin Express03-10

China Traditional Chinese Medicine Holdings Co. Limited (TRAD CHI MED, 00570) will convene a board meeting on 20 March 2026 to review and approve the consolidated financial results for the year ended 31 December 2025. The agenda also includes deliberation on the declaration of a potential final dividend.

The board currently comprises 12 directors: three executive directors (YANG Jun, LI Hongjian, PENG Li), five non-executive directors (LIU Haijian, LI Xiangrong, ZU Jing, XU Jinghui, HUANG Hao) and four independent non-executive directors (XIE Rong, YU Tze Shan Hailson, QIN Ling, LI Weidong).

The company disclosed the meeting schedule through an announcement filed with the Hong Kong Stock Exchange on 10 March 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1176253694?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-10 16:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1176253694","market":"hk","top_or_hot":-1,"title":"TRAD CHI MED (00570) Sets 20 March 2026 Board Meeting to Approve FY 2025 Results and Evaluate Final Dividend","media":"Bulletin Express","content":"<p>China Traditional Chinese Medicine Holdings Co. Limited (TRAD CHI MED, 00570) will convene a board meeting on 20 March 2026 to review and approve the consolidated financial results for the year ended 31 December 2025. The agenda also includes deliberation on the declaration of a potential final dividend.</p>\n<p>The board currently comprises 12 directors: three executive directors (YANG Jun, LI Hongjian, PENG Li), five non-executive directors (LIU Haijian, LI Xiangrong, ZU Jing, XU Jinghui, HUANG Hao) and four independent non-executive directors (XIE Rong, YU Tze Shan Hailson, QIN Ling, LI Weidong).</p>\n<p>The company disclosed the meeting schedule through an announcement filed with the Hong Kong Stock Exchange on 10 March 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TRAD CHI MED (00570) Sets 20 March 2026 Board Meeting to Approve FY 2025 Results and Evaluate Final Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTRAD CHI MED (00570) Sets 20 March 2026 Board Meeting to Approve FY 2025 Results and Evaluate Final Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-10 16:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China Traditional Chinese Medicine Holdings Co. Limited (TRAD CHI MED, 00570) will convene a board meeting on 20 March 2026 to review and approve the consolidated financial results for the year ended 31 December 2025. The agenda also includes deliberation on the declaration of a potential final dividend.</p>\n<p>The board currently comprises 12 directors: three executive directors (YANG Jun, LI Hongjian, PENG Li), five non-executive directors (LIU Haijian, LI Xiangrong, ZU Jing, XU Jinghui, HUANG Hao) and four independent non-executive directors (XIE Rong, YU Tze Shan Hailson, QIN Ling, LI Weidong).</p>\n<p>The company disclosed the meeting schedule through an announcement filed with the Hong Kong Stock Exchange on 10 March 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00570","symbol_name":"中国中药","start_time":0,"source_url":"","article_id":"1176253694","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1176253694","pubTimestamp":1773132204,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Traditional Chinese Medicine Holdings Co. Limited (TRAD CHI MED, 00570) will convene a board meeting on 20 March 2026 to review and approve the consolidated financial results for the year ended...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00570":"中国中药"},"translate_title":"TRAD CHI MED(00570)定于2026年3月20日召开董事会批准2025财年业绩并评估末期股息","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00570":1},"content_text":"China Traditional Chinese Medicine Holdings Co. Limited (TRAD CHI MED, 00570) will convene a board meeting on 20 March 2026 to review and approve the consolidated financial results for the year ended 31 December 2025. The agenda also includes deliberation on the declaration of a potential final dividend.\nThe board currently comprises 12 directors: three executive directors (YANG Jun, LI Hongjian, PENG Li), five non-executive directors (LIU Haijian, LI Xiangrong, ZU Jing, XU Jinghui, HUANG Hao) and four independent non-executive directors (XIE Rong, YU Tze Shan Hailson, QIN Ling, LI Weidong).\nThe company disclosed the meeting schedule through an announcement filed with the Hong Kong Stock Exchange on 10 March 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1176253694","isCrawlerRequest":true}